BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
USA - NASDAQ:BVS - US09075A1088 - Common Stock
6.71 USD
0 (0%)
6.71 USD
0 (0%)
We assign a fundamental rating of 4 out of 10 to BVS. BVS was compared to 191 industry peers in the Health Care Equipment & Supplies industry. BVS has a medium profitability rating, but doesn't score so well on its financial health evaluation. BVS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
BVS had positive earnings in the past year.
BVS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
BVS has a Return On Assets of -0.02%. This is in the better half of the industry: BVS outperforms 71.20% of its industry peers.
BVS has a Return On Equity of -0.10%. This is in the better half of the industry: BVS outperforms 71.73% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.08%, BVS belongs to the top of the industry, outperforming 80.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.02% | ||
| ROE | -0.1% | ||
| ROIC | 6.08% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BVS has a Operating Margin of 7.11%. This is in the better half of the industry: BVS outperforms 74.35% of its industry peers.
BVS's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 67.60%, BVS is in the better half of the industry, outperforming 74.35% of the companies in the same industry.
BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.11% | ||
| PM (TTM) | N/A | ||
| GM | 67.6% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BVS is destroying value.
The number of shares outstanding for BVS has been increased compared to 1 year ago.
BVS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BVS has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.05, we must say that BVS is in the distress zone and has some risk of bankruptcy.
BVS's Altman-Z score of 1.05 is in line compared to the rest of the industry. BVS outperforms 52.88% of its industry peers.
The Debt to FCF ratio of BVS is 10.30, which is on the high side as it means it would take BVS, 10.30 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 10.30, BVS is doing good in the industry, outperforming 73.30% of the companies in the same industry.
BVS has a Debt/Equity ratio of 1.90. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.90, BVS is not doing good in the industry: 83.25% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 10.3 | ||
| Altman-Z | 1.05 |
ROIC/WACC0.72
WACC8.49%
2.3 Liquidity
A Current Ratio of 1.48 indicates that BVS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.48, BVS is doing worse than 75.39% of the companies in the same industry.
BVS has a Quick Ratio of 1.48. This is a bad value and indicates that BVS is not financially healthy enough and could expect problems in meeting its short term obligations.
BVS has a worse Quick ratio (0.96) than 78.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 31.58% over the past year.
The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
BVS shows a small growth in Revenue. In the last year, the Revenue has grown by 5.07%.
The Revenue has been growing by 11.01% on average over the past years. This is quite good.
EPS 1Y (TTM)31.58%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%10.53%
Revenue 1Y (TTM)5.07%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-2.35%
3.2 Future
The Earnings Per Share is expected to grow by 25.28% on average over the next years. This is a very strong growth
Based on estimates for the next years, BVS will show a small growth in Revenue. The Revenue will grow by 4.19% on average per year.
EPS Next Y38.25%
EPS Next 2Y32.75%
EPS Next 3Y25.28%
EPS Next 5YN/A
Revenue Next Year0.2%
Revenue Next 2Y3.49%
Revenue Next 3Y4.19%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 13.42, the valuation of BVS can be described as correct.
Based on the Price/Earnings ratio, BVS is valued cheaply inside the industry as 87.43% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BVS to the average of the S&P500 Index (27.86), we can say BVS is valued rather cheaply.
With a Price/Forward Earnings ratio of 8.10, the valuation of BVS can be described as very reasonable.
BVS's Price/Forward Earnings ratio is rather cheap when compared to the industry. BVS is cheaper than 97.38% of the companies in the same industry.
BVS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.29.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.42 | ||
| Fwd PE | 8.1 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BVS is valued cheaper than 90.05% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 89.01% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.27 | ||
| EV/EBITDA | 9.84 |
4.3 Compensation for Growth
BVS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BVS's earnings are expected to grow with 25.28% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y32.75%
EPS Next 3Y25.28%
5. Dividend
5.1 Amount
No dividends for BVS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.71
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners73.56%
Inst Owner Change2.29%
Ins Owners2.54%
Ins Owner Change3.36%
Market Cap554.78M
Analysts77.5
Price Target14.96 (122.95%)
Short Float %3.27%
Short Ratio4.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)119.26%
Min EPS beat(2)-0.99%
Max EPS beat(2)239.51%
EPS beat(4)3
Avg EPS beat(4)103.69%
Min EPS beat(4)-0.99%
Max EPS beat(4)239.51%
EPS beat(8)7
Avg EPS beat(8)172.93%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)0.07%
Revenue beat(4)3
Avg Revenue beat(4)2.02%
Min Revenue beat(4)-0.04%
Max Revenue beat(4)4.79%
Revenue beat(8)7
Avg Revenue beat(8)4.23%
Revenue beat(12)9
Avg Revenue beat(12)1.98%
Revenue beat(16)11
Avg Revenue beat(16)1.72%
PT rev (1m)4.76%
PT rev (3m)-2.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.61%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.42 | ||
| Fwd PE | 8.1 | ||
| P/S | 0.98 | ||
| P/FCF | 16.27 | ||
| P/OCF | 15.31 | ||
| P/B | 3.44 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.84 |
EPS(TTM)0.5
EY7.45%
EPS(NY)0.83
Fwd EY12.34%
FCF(TTM)0.41
FCFY6.15%
OCF(TTM)0.44
OCFY6.53%
SpS6.82
BVpS1.95
TBVpS-2.82
PEG (NY)0.35
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.02% | ||
| ROE | -0.1% | ||
| ROCE | 7.7% | ||
| ROIC | 6.08% | ||
| ROICexc | 6.49% | ||
| ROICexgc | 33.79% | ||
| OM | 7.11% | ||
| PM (TTM) | N/A | ||
| GM | 67.6% | ||
| FCFM | 6.04% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y44.62%
ROICexcg growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score7
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 10.3 | ||
| Debt/EBITDA | 3.46 | ||
| Cap/Depr | 4.42% | ||
| Cap/Sales | 0.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 40.86% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.05 |
F-Score7
WACC8.49%
ROIC/WACC0.72
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.58%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%10.53%
EPS Next Y38.25%
EPS Next 2Y32.75%
EPS Next 3Y25.28%
EPS Next 5YN/A
Revenue 1Y (TTM)5.07%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-2.35%
Revenue Next Year0.2%
Revenue Next 2Y3.49%
Revenue Next 3Y4.19%
Revenue Next 5YN/A
EBIT growth 1Y188.15%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year16.75%
EBIT Next 3Y12.98%
EBIT Next 5YN/A
FCF growth 1Y336.04%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y103.28%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%